108Indexed trials
Market Rank #31 · Evidence Tier A
Russia
Neuroscience Intelligence
Russia neuroscience intelligence: 108 indexed trials, 76 institutions, research score 33.79.
11Recruiting
76Research institutions
33.8Research score
Evidence profile
51Sponsors
18Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 33.8 · Data confidence 100.00 · Evidence 33.8
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons19trials
epilepsy18trials
alzheimers14trials
depression8trials
multiple_sclerosis8trials
other_neurology7trials
schizophrenia7trials
stroke7trials
bipolar_disorder4trials
neuromuscular4trials
Leading indexed sponsors
Merck Sharp & Dohme LLC12trials
Hoffmann-La Roche11trials
Sumitomo Pharma America, Inc.6trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5trials
Pfizer5trials
Eli Lilly and Company5trials
Genzyme, a Sanofi Company4trials
GlaxoSmithKline4trials
Boehringer Ingelheim3trials
Ipsen3trials